Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 6.590
Filter
1.
Nat Microbiol ; 9(7): 1686-1699, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38898217

ABSTRACT

The continuing emergence of invasive fungal pathogens poses an increasing threat to public health. Here, through the China Hospital Invasive Fungal Surveillance Net programme, we identified two independent cases of human infection with a previously undescribed invasive fungal pathogen, Rhodosporidiobolus fluvialis, from a genus in which many species are highly resistant to fluconazole and caspofungin. We demonstrate that R. fluvialis can undergo yeast-to-pseudohyphal transition and that pseudohyphal growth enhances its virulence, revealed by the development of a mouse model. Furthermore, we show that mouse infection or mammalian body temperature induces its mutagenesis, allowing the emergence of hypervirulent mutants favouring pseudohyphal growth. Temperature-induced mutagenesis can also elicit the development of pan-resistance to three of the most commonly used first-line antifungals (fluconazole, caspofungin and amphotericin B) in different Rhodosporidiobolus species. Furthermore, polymyxin B was found to exhibit potent activity against the pan-resistant Rhodosporidiobolus mutants. Collectively, by identifying and characterizing a fungal pathogen in the drug-resistant genus Rhodosporidiobolus, we provide evidence that temperature-dependent mutagenesis can enable the development of pan-drug resistance and hypervirulence in fungi, and support the idea that global warming can promote the evolution of new fungal pathogens.


Subject(s)
Antifungal Agents , Mutagenesis , Animals , Mice , Humans , Virulence/genetics , Antifungal Agents/pharmacology , China , Body Temperature , Disease Models, Animal , Ascomycota/genetics , Ascomycota/pathogenicity , Ascomycota/drug effects , Caspofungin/pharmacology , Microbial Sensitivity Tests , Fluconazole/pharmacology , Mycoses/microbiology , Drug Resistance, Multiple, Fungal/genetics , Drug Resistance, Fungal/genetics
2.
PLoS One ; 19(6): e0305228, 2024.
Article in English | MEDLINE | ID: mdl-38870137

ABSTRACT

The chytrid fungus Batrachochytrium salamandrivorans [Bsal] is causing declines in the amphibian populations. After a decade of mapping the pathogen in Europe, where it is causing dramatic outbreaks, and North America, where its arrival would affect to the salamander's biodiversity hotspot, little is known about its current status in Asia, from presumably is native. Japan has several species considered as potential carriers, but no regulation is implemented against Bsal spreading. Previous Bsal known presence detected various cases on the Okinawa Island, southwestern Japan. Previous studies on its sister species, B. dendrobatidis presented a high genomic variation in this area and particularly on Cynops ensicauda. Here, we have done the largest monitoring to date in Japan on the Cynops genus, focusing on Okinawa Island and updating its distribution and providing more information to unravel the still unknown origin of Bsal. Interestingly, we have provided revealing facts about different detectability depending on the used molecular techniques and changes in its Japanese distribution. All in all, the Bsal presence in Japan, together with its low variability in the sequenced amplicons, and the lack of apparent mortalities, may indicate that this part of Asia has a high diversity of chytrids.


Subject(s)
Batrachochytrium , Urodela , Animals , Japan , Urodela/microbiology , Batrachochytrium/genetics , Phylogeny , Genetic Variation , Biodiversity , Chytridiomycota/genetics , Mycoses/microbiology , Mycoses/veterinary , Mycoses/epidemiology , East Asian People
3.
J Zoo Wildl Med ; 55(2): 540-546, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38875213

ABSTRACT

This report describes Schizangiella infections in colubrid and viperid snakes. A captive eastern ratsnake (Pantherophis alleghaniensis) was presented for a large intraoral mass associated with the mandible. The mass was debulked and histologic examination revealed severe, granulomatous stomatitis with intralesional fungi exhibiting morphologic features consistent with Schizangiella serpentis. PCR and sequencing of affected tissues confirmed S. serpentis. Because of declining health, the ratsnake was euthanized and postmortem examination identified a disseminated S. serpentis infection involving the skeletal musculature, lung, kidney, mesentery, and mandible. A wild-caught timber rattlesnake (Crotalus horridus) was presented for cutaneous lesions, weakness, and lethargy and later died. Postmortem examination revealed a mass-like structure in the esophagus characterized by high numbers of Schizangiella-like fungi associated with extensive granulomatous inflammation; the snake also had cutaneous mycosis suggestive of ophidiomycosis. This is the first report to document the unique morphologic features of S. serpentis in tissues and the presentation of schizangiellosis in snakes. Schizangiellosis should be considered as a differential diagnosis for nodular lesions involving the oral cavity and/or the gastrointestinal tract of snakes.


Subject(s)
Crotalus , Animals , Colubridae , Mycoses/veterinary , Mycoses/microbiology , Mycoses/pathology , Mycoses/diagnosis , Thelazioidea/isolation & purification , Animals, Zoo , Male , Female , Venomous Snakes
4.
BMC Infect Dis ; 24(1): 605, 2024 Jun 19.
Article in English | MEDLINE | ID: mdl-38898444

ABSTRACT

BACKGROUND PAECILOMYCES: and Penicillium are considered as rare opportunistic pathogens in immunocompromised hosts, and pneumonia caused by Paecilomyces and Penicillium is rare. In this study, we present first case of severe pneumonia with pleural effusion caused by co-infection of Paecilomyces variotii (P. variotii) and Penicillium oxalicum (P. oxalicum) in a 66-year-old female with poorly controlled type 2 diabetes. CASE PRESENTATION: A 56-year-old woman patient presented to hospital for nausea, poor appetite, and vomiting for one day. On the second day of admission, blood culture and renal puncture fluid culture grew multidrug-resistant Escherichia coli (imipenem/cilastatin sensitive), and she received combination therapy with imipenem/cilastatin (1 g, every 8 h) and vancomycin (0.5 g, every 12 h). On the fourth day, she developed symptoms of respiratory failure. Pulmonary computed tomography (CT) showed an increase in pneumonia compared to before, with minor pleural effusion on both sides. Two fungi were isolated repeatedly from BALF culture, which were confirmed as P. variotii and P. oxalicum by Internal transcribed spacer (ITS) sequencing. Her pleural effusion was completely absorbed, pneumonia symptoms have significantly improved and discharged with receiving liposomal amphotericin B treatment for four weeks. CONCLUSIONS: It is worth noting that clinicians and laboratory personnel should not simply consider Paecilomyces and Penicillium species as contaminants, especially in immunocompromised patients. Early fungal identification and antifungal drug sensitivity are crucial for clinical drug selection and patient prognosis.


Subject(s)
Coinfection , Diabetes Mellitus, Type 2 , Paecilomyces , Penicillium , Pleural Effusion , Humans , Female , Penicillium/isolation & purification , Pleural Effusion/microbiology , Pleural Effusion/drug therapy , Middle Aged , Aged , Diabetes Mellitus, Type 2/complications , Coinfection/microbiology , Coinfection/drug therapy , Paecilomyces/isolation & purification , Pneumonia/microbiology , Pneumonia/drug therapy , Mycoses/microbiology , Mycoses/drug therapy , Immunocompromised Host , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use
6.
Med Mycol ; 62(6)2024 Jun 27.
Article in English | MEDLINE | ID: mdl-38935909

ABSTRACT

The World Health Organization, in response to the growing burden of fungal disease, established a process to develop a fungal pathogen priority list. This systematic review aimed to evaluate the epidemiology and impact of infections caused by Talaromyces marneffei, Coccidioides species, and Paracoccidioides species. PubMed and Web of Sciences databases were searched to identify studies published between 1 January 2011 and 23 February 2021 reporting on mortality, complications and sequelae, antifungal susceptibility, preventability, annual incidence, and trends. Overall, 25, 17, and 6 articles were included for T. marneffei, Coccidioides spp. and Paracoccidioides spp., respectively. Mortality rates were high in those with invasive talaromycosis and paracoccidioidomycosis (up to 21% and 22.7%, respectively). Hospitalization was frequent in those with coccidioidomycosis (up to 84%), and while the duration was short (mean/median 3-7 days), readmission was common (38%). Reduced susceptibility to fluconazole and echinocandins was observed for T. marneffei and Coccidioides spp., whereas >88% of T. marneffei isolates had minimum inhibitory concentration values ≤0.015 µg/ml for itraconazole, posaconazole, and voriconazole. Risk factors for mortality in those with talaromycosis included low CD4 counts (odds ratio 2.90 when CD4 count <200 cells/µl compared with 24.26 when CD4 count <50 cells/µl). Outbreaks of coccidioidomycosis and paracoccidioidomycosis were associated with construction work (relative risk 4.4-210.6 and 5.7-times increase, respectively). In the United States of America, cases of coccidioidomycosis increased between 2014 and 2017 (from 8232 to 14 364/year). National and global surveillance as well as more detailed studies to better define sequelae, risk factors, outcomes, global distribution, and trends are required.


Subject(s)
Antifungal Agents , Coccidioides , Paracoccidioides , Talaromyces , World Health Organization , Talaromyces/isolation & purification , Talaromyces/classification , Talaromyces/drug effects , Humans , Paracoccidioides/isolation & purification , Paracoccidioides/drug effects , Paracoccidioides/classification , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Coccidioides/isolation & purification , Coccidioides/classification , Coccidioides/drug effects , Mycoses/epidemiology , Mycoses/microbiology , Mycoses/mortality , Paracoccidioidomycosis/epidemiology , Paracoccidioidomycosis/microbiology , Paracoccidioidomycosis/drug therapy , Coccidioidomycosis/epidemiology , Coccidioidomycosis/microbiology , Microbial Sensitivity Tests
8.
Med Mycol ; 62(6)2024 Jun 27.
Article in English | MEDLINE | ID: mdl-38935914

ABSTRACT

Recognizing the growing global burden of fungal infections, the World Health Organization established a process to develop a priority list of fungal pathogens (FPPL). In this systematic review, we aimed to evaluate the epidemiology and impact of infections caused by Fusarium spp., Scedosporium spp., and Lomentospora prolificans to inform the first FPPL. PubMed and Web of Sciences databases were searched to identify studies published between January 1, 2011 and February 23, 2021, reporting on mortality, complications and sequelae, antifungal susceptibility, preventability, annual incidence, and trends. Overall, 20, 11, and 9 articles were included for Fusarium spp., Scedosporium spp., and L. prolificans, respectively. Mortality rates were high in those with invasive fusariosis, scedosporiosis, and lomentosporiosis (42.9%-66.7%, 42.4%-46.9%, and 50.0%-71.4%, respectively). Antifungal susceptibility data, based on small isolate numbers, showed high minimum inhibitory concentrations (MIC)/minimum effective concentrations for most currently available antifungal agents. The median/mode MIC for itraconazole and isavuconazole were ≥16 mg/l for all three pathogens. Based on limited data, these fungi are emerging. Invasive fusariosis increased from 0.08 cases/100 000 admissions to 0.22 cases/100 000 admissions over the time periods of 2000-2009 and 2010-2015, respectively, and in lung transplant recipients, Scedosporium spp. and L. prolificans were only detected from 2014 onwards. Global surveillance to better delineate antifungal susceptibility, risk factors, sequelae, and outcomes is required.


Subject(s)
Antifungal Agents , Fusarium , Microbial Sensitivity Tests , Scedosporium , Humans , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Fusarium/drug effects , Fusarium/isolation & purification , Scedosporium/drug effects , Scedosporium/isolation & purification , Scedosporium/classification , World Health Organization , Mycoses/epidemiology , Mycoses/microbiology , Fusariosis/microbiology , Fusariosis/epidemiology , Ascomycota/drug effects , Invasive Fungal Infections
10.
Article in Chinese | MEDLINE | ID: mdl-38811177

ABSTRACT

Objective: By conducting a retrospective analysis of the clinical data of 14 patients diagnosed with invasive fungal rhinosinusitis (IFRS) confirmed by metagenomics next generation sequencing (mNGS) technology, we aim to explore the rapid diagnosis value of mNGS in IFRS. Methods: The clinical data of 14 IFRS patients admitted to TianJin First Central Hospital were retrospectively analyzed from February 2021 to October 2023. The study cohort comprised 8 males and 6 females, with ages ranging from 14 to 77 years. All patients were diagnosed as IFRS by performing mNGS sequencing technology of nasal sinus lesion biopsy specimens. Clinical data such as laboratory examination, imaging examination, histopathological examination results, treatment plan and prognosis were summarized and analyzed. Results: All 14 patients were diagnosed as IFRS, with mNGS detecting pathogens such as Rhizopus (7 cases), Aspergillus (5 cases), Trichoderma (1 case), and Scedosporium apiospermum (1 case). Follow-up evaluations were conducted for a period ranging from 2 months to 2 years post-treatment. At the end of follow-up, 11 out of 14 IFRS patients achieved a complete cure with no signs of recurrence, while the symptoms of the remaining 3 patients significantly improved with comprehensive treatment. Conclusion: mNGS emerges as a highly effective diagnostic tool for IFRS, providing valuable microbiological evidence for clinical diagnosis and demonstrating promising clinical utility.


Subject(s)
Sinusitis , Humans , Male , Female , Sinusitis/microbiology , Sinusitis/diagnosis , Retrospective Studies , Middle Aged , Aged , Adolescent , Adult , Young Adult , Metagenomics/methods , High-Throughput Nucleotide Sequencing , Mycoses/diagnosis , Mycoses/microbiology , Aspergillus/isolation & purification , Rhinitis/diagnosis , Rhinitis/microbiology , Rhizopus/isolation & purification , Scedosporium/isolation & purification
11.
PLoS One ; 19(5): e0298591, 2024.
Article in English | MEDLINE | ID: mdl-38758948

ABSTRACT

Amphibians globally suffer from emerging infectious diseases like chytridiomycosis caused by the continuously spreading chytrid fungi. One is Batrachochytrium salamandrivorans (Bsal) and its disease ‒ the 'salamander plague' ‒ which is lethal to several caudate taxa. Recently introduced into Western Europe, long distance dispersal of Bsal, likely through human mediation, has been reported. Herein we study if Alpine salamanders (Salamandra atra and S. lanzai) are yet affected by the salamander plague in the wild. Members of the genus Salamandra are highly susceptible to Bsal leading to the lethal disease. Moreover, ecological modelling has shown that the Alps and Dinarides, where Alpine salamanders occur, are generally suitable for Bsal. We analysed skin swabs of 818 individuals of Alpine salamanders and syntopic amphibians at 40 sites between 2017 to 2022. Further, we compiled those with published data from 319 individuals from 13 sites concluding that Bsal infections were not detected. Our results suggest that the salamander plague so far is absent from the geographic ranges of Alpine salamanders. That means that there is still a chance to timely implement surveillance strategies. Among others, we recommend prevention measures, citizen science approaches, and ex situ conservation breeding of endemic salamandrid lineages.


Subject(s)
Batrachochytrium , Mycoses , Urodela , Animals , Batrachochytrium/genetics , Batrachochytrium/pathogenicity , Mycoses/veterinary , Mycoses/microbiology , Mycoses/epidemiology , Urodela/microbiology , Communicable Diseases, Emerging/microbiology , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/veterinary , Salamandra/microbiology , Europe/epidemiology , Chytridiomycota
12.
Front Cell Infect Microbiol ; 14: 1366908, 2024.
Article in English | MEDLINE | ID: mdl-38725449

ABSTRACT

Background: Metagenomic next-generation sequencing (mNGS) is a novel non-invasive and comprehensive technique for etiological diagnosis of infectious diseases. However, its practical significance has been seldom reported in the context of hematological patients with high-risk febrile neutropenia, a unique patient group characterized by neutropenia and compromised immune responses. Methods: This retrospective study evaluated the results of plasma cfDNA sequencing in 164 hematological patients with high-risk febrile neutropenia. We assessed the diagnostic efficacy and clinical impact of mNGS, comparing it with conventional microbiological tests. Results: mNGS identified 68 different pathogens in 111 patients, whereas conventional methods detected only 17 pathogen types in 36 patients. mNGS exhibited a significantly higher positive detection rate than conventional methods (67.7% vs. 22.0%, P < 0.001). This improvement was consistent across bacterial (30.5% vs. 9.1%), fungal (19.5% vs. 4.3%), and viral (37.2% vs. 9.1%) infections (P < 0.001 for all comparisons). The anti-infective treatment strategies were adjusted for 51.2% (84/164) of the patients based on the mNGS results. Conclusions: mNGS of plasma cfDNA offers substantial promise for the early detection of pathogens and the timely optimization of anti-infective therapies in hematological patients with high-risk febrile neutropenia.


Subject(s)
Febrile Neutropenia , High-Throughput Nucleotide Sequencing , Metagenomics , Humans , Metagenomics/methods , Male , Retrospective Studies , High-Throughput Nucleotide Sequencing/methods , Female , Middle Aged , Febrile Neutropenia/microbiology , Febrile Neutropenia/blood , Febrile Neutropenia/diagnosis , Adult , Aged , Young Adult , Adolescent , Aged, 80 and over , Bacterial Infections/diagnosis , Bacterial Infections/microbiology , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/classification , Mycoses/diagnosis , Mycoses/microbiology , Virus Diseases/diagnosis , Virus Diseases/virology
13.
Dis Aquat Organ ; 158: 123-132, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38813853

ABSTRACT

The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) causes chytridiomycosis, a disease among the main causes of amphibian declines worldwide. However, Bd studies on Neotropical amphibians from temperate areas are scarce. We present a comprehensive survey of Bd in Uruguay, in temperate central eastern South America, carried out between 2006 and 2014. Skin swabs of 535 specimens of 21 native and exotic frogs were tested by PCR. We used individual-level data to examine the relationship between infection, climatic variables, and their effects on body condition and the number of prey items found in stomach contents. Infection was widespread in free-ranging anurans with an overall prevalence of 41.9%, detected in 15 native species, wild American bullfrogs Aquarana catesbeiana, and captive specimens of Ceratophrys ornata and Xenopus laevis. Three haplotypes of the Bd ITS region were identified in native amphibians, all belonging to the global panzootic lineage (BdGPL), of which only one was present in exotic hosts. Despite high infection frequencies in different anurans, we found no evidence of morbidity or mortality attributable to chytridiomycosis, and we observed no discernible impact on body condition or consumed prey. Climatic conditions at the time of our surveys suggested that the chance of infection is associated with monthly mean temperature, mean humidity, and total precipitation. Temperatures below 21°C combined with moderate humidity and pronounced rainfall may increase the likelihood of infection. Multiple haplotypes of BdGPL combined with high frequencies of infection suggest an enzootic pattern in native species, underscoring the need for continued monitoring.


Subject(s)
Climate , Mycoses , Animals , Mycoses/veterinary , Mycoses/epidemiology , Mycoses/microbiology , Uruguay/epidemiology , Batrachochytrium/genetics , Anura/microbiology , Chytridiomycota/isolation & purification
14.
Dis Aquat Organ ; 158: 173-178, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38813857

ABSTRACT

Working with aquatic organisms often requires handling multiple individuals in a single session, potentially resulting in cross-contamination by live pathogens or DNA. Most researchers address this problem by disposing of gloves between animals. However, this generates excessive waste and may be impractical for processing very slippery animals that might be easier to handle with cotton gloves. We tested methods to decontaminate cotton or nitrile gloves after contamination with cultured Batrachochytrium dendrobatidis (Bd) or after handling heavily Bd-infected Xenopus laevis with layered cotton and nitrile gloves. Bleach eliminated detectable Bd DNA from culture-contaminated nitrile gloves, but gloves retained detectable Bd DNA following ethanol disinfection. After handling a Bd-infected frog, Bd DNA contamination was greatly reduced by removal of the outer cotton glove, after which either bleach decontamination or ethanol decontamination followed by drying hands with a paper towel lowered Bd DNA below the detection threshold of our assay. These results provide new options to prevent pathogen or DNA cross-contamination, especially when handling slippery aquatic organisms. However, tradeoffs should be considered when selecting an animal handling procedure, such as the potential for cotton gloves to abrade amphibian skin or disrupt skin mucus. Disposing of gloves between animals should remain the gold standard for maintaining biosecurity in sensitive situations.


Subject(s)
Decontamination , Gloves, Protective , Animals , Decontamination/methods , Gloves, Protective/microbiology , Batrachochytrium , DNA, Fungal , Mycoses/veterinary , Mycoses/prevention & control , Mycoses/microbiology
15.
Ecol Lett ; 27(5): e14431, 2024 May.
Article in English | MEDLINE | ID: mdl-38712705

ABSTRACT

There is a rich literature highlighting that pathogens are generally better adapted to infect local than novel hosts, and a separate seemingly contradictory literature indicating that novel pathogens pose the greatest threat to biodiversity and public health. Here, using Batrachochytrium dendrobatidis, the fungus associated with worldwide amphibian declines, we test the hypothesis that there is enough variance in "novel" (quantified by geographic and phylogenetic distance) host-pathogen outcomes to pose substantial risk of pathogen introductions despite local adaptation being common. Our continental-scale common garden experiment and global-scale meta-analysis demonstrate that local amphibian-fungal interactions result in higher pathogen prevalence, pathogen growth, and host mortality, but novel interactions led to variable consequences with especially virulent host-pathogen combinations still occurring. Thus, while most pathogen introductions are benign, enough variance exists in novel host-pathogen outcomes that moving organisms around the planet greatly increases the chance of pathogen introductions causing profound harm.


Subject(s)
Batrachochytrium , Host-Pathogen Interactions , Animals , Batrachochytrium/genetics , Batrachochytrium/physiology , Anura/microbiology , Amphibians/microbiology , Mycoses/veterinary , Mycoses/microbiology , Adaptation, Physiological , Phylogeny
17.
Ther Adv Respir Dis ; 18: 17534666241254090, 2024.
Article in English | MEDLINE | ID: mdl-38780228

ABSTRACT

BACKGROUND: A significant decline in pulmonary exacerbation rates has been reported in CF patients homozygous for F508del treated with lumacaftor/ivacaftor. However, it is still unclear whether this reduction reflects a diminished microbiological burden. OBJECTIVES: The aim of this study was to determine the impact of lumacaftor/ivacaftor on the bacterial and fungal burden. DESIGN: The study is a prospective multicenter cohort study including 132 CF patients homozygous for F508del treated with lumacaftor/ivacaftor. METHODS: Clinical parameters as well as bacterial and fungal outcomes 1 year after initiation of lumacaftor/ivacaftor were compared to data from 2 years prior to initiation of the treatment. Changes in the slope of the outcomes before and after the onset of treatment were assessed. RESULTS: Lung function measured as ppFEV1 (p < 0.001), body mass index (BMI) in adults (p < 0.001), and BMI z-score in children (p = 0.007) were improved after initiation of lumacaftor/ivacaftor. In addition, the slope of the prevalence of Streptococcus pneumoniae (p = 0.007) and Stenotrophomonas maltophilia (p < 0.001) shifted from positive to negative, that is, became less prevalent, 1 year after treatment, while the slope for Candida albicans (p = 0.009), Penicillium spp (p = 0.026), and Scedosporium apiospermum (p < 0.001) shifted from negative to positive. CONCLUSION: The current study showed a significant improvement in clinical parameters and a reduction of some of CF respiratory microorganisms 1 year after starting with lumacaftor/ivacaftor. However, no significant changes were observed for Pseudomonas aeruginosa, Staphylococcus aureus, or Aspergillus fumigatus, key pathogens in the CF context.


Subject(s)
Aminophenols , Aminopyridines , Benzodioxoles , Cystic Fibrosis , Drug Combinations , Quinolones , Humans , Cystic Fibrosis/drug therapy , Cystic Fibrosis/microbiology , Cystic Fibrosis/physiopathology , Male , Prospective Studies , Female , Aminophenols/therapeutic use , Benzodioxoles/therapeutic use , Child , Adult , Young Adult , Adolescent , Aminopyridines/pharmacology , Aminopyridines/administration & dosage , Aminopyridines/therapeutic use , Aminopyridines/adverse effects , Quinolones/pharmacology , Sweden , Treatment Outcome , Mycoses/microbiology , Mycoses/drug therapy , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/diagnosis , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Lung/microbiology , Lung/physiopathology , Lung/drug effects , Chloride Channel Agonists/therapeutic use , Time Factors , Fungi/isolation & purification , Bacterial Infections/microbiology , Bacterial Infections/drug therapy
18.
BMC Infect Dis ; 24(1): 506, 2024 May 21.
Article in English | MEDLINE | ID: mdl-38773459

ABSTRACT

BACKGROUND: The sharp increase in fungal infections, insufficient diagnostic and treatment capabilities for fungal infections, poor prognosis of patients with fungal infections as well as the increasing drug resistance of fungi are serious clinical problems. It is necessary to explore the implementation and evaluation methods of antifungal stewardship (AFS) to promote the standardized use of antifungal drugs. METHODS: The AFS programme was implemented at a tertiary first-class hospital in China using a plan-do-check-act (PDCA) quality management tool. A baseline investigation was carried out to determine the utilization of antifungal drugs in pilot hospitals, analyse the existing problems and causes, and propose corresponding solutions. The AFS programme was proposed and implemented beginning in 2021, and included various aspects, such as team building, establishment of regulations, information construction, prescription review and professional training. The management effectiveness was recorded from multiple perspectives, such as the consumption of antifungal drugs, the microbial inspection rate of clinical specimens, and the proportion of rational prescriptions. The PDCA management concept was used for continuous improvement to achieve closed-loop management. RESULTS: In the first year after the implementation of the AFS programme, the consumption cost, use intensity and utilization rate of antifungal drugs decreased significantly (P < 0.01). The proportion of rational antifungal drug prescriptions markedly increased, with the proportion of prescriptions with indications increasing from 86.4% in 2019 to 97.0% in 2022, and the proportion of prescriptions with appropriate usage and dosage increased from 51.9 to 87.1%. In addition, after the implementation of the AFS programme, physicians' awareness of the need to complete microbial examinations improved, and the number of fungal cultures and serological examinations increased substantially. Statistics from drug susceptibility tests revealed a decrease in the resistance rate of Candida to fluconazole. CONCLUSION: This study indicated that the combination of AFS and the PDCA cycle could effectively reduce antifungal consumption and promote the rational use of antifungal drugs, providing a reference for other health care systems to reduce the overuse of antifungal drugs and delay the progression of fungal resistance.


Subject(s)
Antifungal Agents , Antimicrobial Stewardship , Mycoses , Tertiary Care Centers , Antifungal Agents/therapeutic use , Humans , China , Mycoses/drug therapy , Mycoses/microbiology , Drug Resistance, Fungal , Drug Utilization/standards , Drug Utilization/statistics & numerical data
19.
Environ Microbiol Rep ; 16(3): e13274, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38775382

ABSTRACT

The pathogenic fungus Batrachochytrium dendrobatidis has caused declines of amphibians worldwide. Yet our understanding of how water quality influences fungal pathogenicity is limited. Here, we reviewed experimental studies on the effect of water quality on this pathogen to determine which parameters impacted disease dynamics consistently. The strongest evidence for protective effects is salinity which shows strong antifungal properties in hosts at natural levels. Although many fungicides had detrimental effects on the fungal pathogen in vitro, their impact on the host is variable and they can worsen infection outcomes. However, one fungicide, epoxiconazole, reduced disease effects experimentally and likely in the field. While heavy metals are frequently studied, there is weak evidence that they influence infection outcomes. Nitrogen and phosphorous do not appear to impact pathogen growth or infection in the amphibian host. The effects of other chemicals, like pesticides and disinfectants on infection were mostly unclear with mixed results or lacking an in vivo component. Our study shows that water chemistry does impact disease dynamics, but the effects of specific parameters require more investigation. Improving our understanding of how water chemistry influences disease dynamics will help predict the impact of chytridiomycosis, especially in amphibian populations affected by land use changes.


Subject(s)
Amphibians , Batrachochytrium , Water Quality , Animals , Batrachochytrium/drug effects , Amphibians/microbiology , Mycoses/microbiology , Mycoses/veterinary , Mycoses/prevention & control , Salinity , Fungicides, Industrial/pharmacology , Chytridiomycota/drug effects , Chytridiomycota/pathogenicity , Pesticides/pharmacology , Disinfectants/pharmacology , Antifungal Agents/pharmacology
20.
Diagn Microbiol Infect Dis ; 109(3): 116337, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38718662

ABSTRACT

Lecanicillium dimorphum and Lecanicillium psalliotae are fungi that exist naturally in plants or insects, and are generally considered non-pathogenic to humans. However, in this case, we cultured Lecanicillium from the synovial fluid of a patient, and identified it through genome sequencing and sequence alignment as Lecanicillium dimorphum or Lecanicillium psalliotae. Due to the conservation of sequences, we can only identify the genus and not the species. There are very few reports on the human infection and pathogenicity of these two fungi, and this case also cannot completely prove that the pathogenic agent is this fungus. But this case also holds clinical significance, as the discovery of Lecanicillium in a human sample can alert the clinician to the presence of an uncommon mold with unclear clinical significance.


Subject(s)
Hypocreales , Mycoses , Humans , Hypocreales/isolation & purification , Hypocreales/genetics , Hypocreales/classification , Mycoses/microbiology , Mycoses/diagnosis , Synovial Fluid/microbiology , Male , Phylogeny , Sequence Analysis, DNA , DNA, Fungal/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...